Baxter

Be Biopharma Expands Leadership Team as Company Transitions to Clinical Stage Organization

Retrieved on: 
Thursday, January 4, 2024
Health, Genetics, Research, Pharmaceutical, Science, Biotechnology, SCD, Associate, Accounting, Cantor Fitzgerald, BCMS, Immunology, Sickle cell disease, American Journal, BLA, CFO, Drug development, Medical Center, CMO, Haemophilia, Occidental College, Rockwell Medical, Pediatrics, Wing, Human services, Advisory Committee, University, Baxter, University of Southern California, Patient, Colgate University, BioMarin Pharmaceutical, USC

Mr. Smith also brings nearly a decade of investment banking experience, providing strategic and financial advice across the healthcare sector.

Key Points: 
  • Mr. Smith also brings nearly a decade of investment banking experience, providing strategic and financial advice across the healthcare sector.
  • “We are thrilled to welcome Angus and Wing to Be Bio,” said Joanne Smith-Farrell, Ph.D., Chief Executive Officer.
  • These accomplished and experienced leaders will further strengthen our leadership team.
  • During his nearly decade-long investment banking tenure, Mr. Smith provided strategic and financial advice to life sciences and healthcare companies.

BioMarin Announces Governance Enhancements and Value Creation Initiatives

Retrieved on: 
Wednesday, December 20, 2023
Adverum Biotechnologies, University, Ambit Biosciences, Daiichi Sankyo, Hill-Rom, Indiana University, Harvard Law School, Baxter, Acceleration, Strategy, Palmer, Pfizer, Biotechnology Innovation Organization, Invacare, Eli Lilly, Hospira, Pediatrics, Chairperson, The Nature Conservancy, Genzyme, American Cancer Society, Therapy, Goldman Sachs, M.B.A, BMRN, ImmunoGen, DSM-IV codes, Shire (pharmaceutical company), IPO, Patient, Proteostasis, BioMarin Pharmaceutical, Corporate development, Dentsply Sirona, Senior, Syneos Health, Iovance Biotherapeutics, Sclerosis, Acquisition, SAN, CIO, Eli Lilly and Company, Interim, Bristol Myers Squibb, Information technology, Management

SAN RAFAEL, Calif., Dec. 20, 2023 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a global biotechnology company dedicated to transforming lives through genetic discovery, today announced several initiatives to enhance corporate governance and long-term shareholder value creation.

Key Points: 
  • SAN RAFAEL, Calif., Dec. 20, 2023 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a global biotechnology company dedicated to transforming lives through genetic discovery, today announced several initiatives to enhance corporate governance and long-term shareholder value creation.
  • "Today's announcements will strengthen our ability to drive better outcomes for patients with genetic diseases and deliver value to all stakeholders.
  • BioMarin plays a pivotal role in the treatment of genetic diseases thanks to its globally leading rare-disease portfolio.
  • We believe the changes announced today put BioMarin in the best position to realize its full potential, and we support Alexander Hardy as the right leader for this chapter of BioMarin's value creation story.

Baxter Advances First Intravenous (IV) Bag Recycling Pilot for U.S. Hospitals

Retrieved on: 
Thursday, December 14, 2023
Recycling, Medical Supplies, Health, Medical Devices, Environment, Hospitals, Other Health, Syringe, NYSE, PVC, Carbon footprint, Baxter International, Nursing, Needle, Patient, Multimedia, Northwestern Memorial Hospital, Polyvinyl chloride, Baxter, Hospital, Northwestern Medicine

Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and technologies, announced the completion of the first phase of its intravenous (IV) bag recycling program pilot.

Key Points: 
  • Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and technologies, announced the completion of the first phase of its intravenous (IV) bag recycling program pilot.
  • View the full release here: https://www.businesswire.com/news/home/20231214638041/en/
    Photo of IV bag recycling provided by Northwestern Medicine.
  • All IV bags involved in this pilot were made of PVC, one of the most widely used plastic materials in medical products.
  • In recent years, Baxter has introduced several programs to facilitate recycling for patients and hospitals in Australia, New Zealand, Guatemala and Colombia.

Baxter Publishes Task Force on Climate-Related Financial Disclosures (TCFD) Report and Is Named to Dow Jones Sustainability Index North America

Retrieved on: 
Monday, December 11, 2023
Medical Supplies, Health, Medical Devices, Hospitals, Research, Science, Pharmaceutical, Disclosure, Carbon, Corporation, NYSE, Risk management, TCFD, Water, Baxter International, International Sustainability Standards Board, DJSI, Patient, Dow Jones, Climate, Corporate social responsibility, Sustainability Accounting Standards Board, Baxter, Medtech, Task force, Renewable energy

The publication of the TCFD report comes as Baxter is named to the Dow Jones Sustainability Index (DJSI) North America for 2023, recognizing the company’s leading sustainability efforts.

Key Points: 
  • The publication of the TCFD report comes as Baxter is named to the Dow Jones Sustainability Index (DJSI) North America for 2023, recognizing the company’s leading sustainability efforts.
  • Baxter has proudly been included in DJSI North America each year since it launched in 2005.
  • The TCFD report complements Baxter’s annual Corporate Responsibility Report , Sustainability Accounting Standards Board (SASB) Index and submissions to CDP Climate and CDP Water , as well as other environmental, social and governance-related disclosures.
  • Moving forward, Baxter expects to report against the TCFD framework in the company’s annual Corporate Responsibility Report.

The Baxter International Foundation and UNICEF Partner to Expand Access to Safe Water and Sanitation in Egypt

Retrieved on: 
Tuesday, November 28, 2023
Other Philanthropy, Utilities, General Health, Health, Energy, Medical Devices, Philanthropy, Foundation, Sanitation, Woman, Corporation, UNICEF USA, NYSE, Climate change, Baxter International, UN, Water cycle, Climate, Weather, Drinking water, Baxter, Rehabilitation, Child, Sustainable Development Goal 6, School, Hygiene, Mother, Water, Death, Partnership, Sewage, UNICEF, Environment, Life, Education, United Nations, WASH, Nursing, Renewable energy

The Baxter International Foundation, the philanthropic arm of Baxter International Inc. (NYSE:BAX), and UNICEF, today announced a partnership to improve access to safe drinking water and sanitation in five water-challenged regions in Egypt.

Key Points: 
  • The Baxter International Foundation, the philanthropic arm of Baxter International Inc. (NYSE:BAX), and UNICEF, today announced a partnership to improve access to safe drinking water and sanitation in five water-challenged regions in Egypt.
  • Baxter and the Baxter International Foundation actively invest in community-focused water projects to improve access to equitable and safe water and sanitation in water-stressed areas.
  • UNICEF and the Baxter International Foundation previously launched a program to improve water security in La Guajira, Colombia in 2021.
  • Through the programs in Egypt and Colombia, UNICEF and the Baxter International Foundation aim to support United Nations Sustainable Development Goal (UN SDG) 6, focusing on Clean Water and Sanitation.

Starbreeze AB (publ) interim report January-September 2023

Retrieved on: 
Thursday, November 16, 2023
Epic Games Store, Weapon, Game, DNA, SEK, Epic, Running, Steam, Torus Games, Fortnite, Baxter, Digital Bros, PlayStation 5, AGM, Studio, Xbox, Environment, DAU, PlayStation, Poverty industry, Video game

STOCKHOLM, Nov. 16, 2023 /PRNewswire/ --

Key Points: 
  • August 10, Starbreeze announced that it will publish Roboquest by RyseUp Studios, version 1.0 to be released on November 7, 2023
    September 22, worldwide launch of PAYDAY 3, Starbreeze has recouped initial investment as of September 30th.
  • November 3, Starbreeze announced that it will publish GodsTV by Melbot Studios for release in 2026.
  • November 10, Starbreeze' Chairman Torgny Hellström announced that he declines re-election at the 2024 AGM.
  • Starbreeze' net sales amounted to close to half a billion SEK during the quarter, of which PAYDAY 3 accounted for SEK 441 million.

Spectral Medical Announces Third Quarter Results and Provides Corporate Update

Retrieved on: 
Thursday, November 9, 2023
BAX, NYSE, Clinical professor, Septic shock, Emory Healthcare, Mortality, FX, Sepsis, Grace note, Balancing, USD, Patient, TSX, Mayo Clinic, Pharmaceutical industry, Nursing, Fine chemical, Baxter, Spectral

TORONTO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced its financial results for the third quarter ended September 30, 2023 and provided a corporate update.

Key Points: 
  • TORONTO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced its financial results for the third quarter ended September 30, 2023 and provided a corporate update.
  • During the third quarter, the Company continued to experience momentum in Tigris Trial enrollment.
  • Dr. John Kellum, Chief Medical Officer of Spectral Medical, stated, “We continue to experience patient enrollment momentum supported by new sites we have onboarded during 2023.
  • The Company concluded the third quarter of 2023 with cash of $5,031,000 compared to $8,414,000 of cash on hand as of December 31, 2022.

Miami Entrepreneur Frances Rios Launches Anthology Book Showcasing Latina Business Leaders' Rise to Excellence; Reframing Perspectives presents 21 Puerto Rican authors

Retrieved on: 
Wednesday, November 8, 2023
Baxter, Santander Bank, ManpowerGroup, Walmart, Hope, The Next Level, Merck, Empowerment, Silver Legacy Resort & Casino, SAN, Woman, Ascena Retail Group, Entertainment, Management, Hotel, Humana, PepsiCo

SAN JUAN, Puerto Rico, Nov. 8, 2023 /PRNewswire-PRWeb/ --  A captivated audience of over 300 leaders was treated to a mosaic of tales capturing resilience, challenges, and triumphs, all shared by 21 distinguished Puerto Rican women business trailblazers. This momentous occasion celebrated the release of the anthology, "Reframing Perspectives: Latina Leaders Who Have Taken Their Story to The Next Level."

Key Points: 
  • This momentous occasion celebrated the release of the anthology, "Reframing Perspectives: Latina Leaders Who Have Taken Their Story to The Next Level."
  • This momentous occasion celebrated the release of the anthology, "Reframing Perspectives: Latina Leaders Who Have Taken Their Story to The Next Level."
  • Frances Rios , a Miami-based entrepreneur, international speaker, and author, is the driving force behind this anthology.
  • Rios passionately conveyed the uniqueness of the anthology, noting the absence of such a focus on Puerto Rican businesswomen.

Baxter Reports Third-Quarter 2023 Results

Retrieved on: 
Thursday, November 2, 2023
Biotechnology, Pharmaceutical, Optical, Medical Supplies, General Health, Health, Medical Devices, Health Technology, Baxter, Warburg Pincus, Tazobactam, BVLOS drone medical delivery trials in India, Piperacillin, Growth, EPS, Risk, BPS, Advent International, Medicine, Breakout Labs, EMR, Eye, Patient, Peritoneal dialysis, CDT, Pharmaceutical industry, Cassette tape, Fine chemical, Hemodialysis, Medication

Under the terms of the definitive agreement, Baxter received total proceeds of $4.25 billion, subject to adjustment for specified items.

Key Points: 
  • Under the terms of the definitive agreement, Baxter received total proceeds of $4.25 billion, subject to adjustment for specified items.
  • Baxter currently expects the Kidney Care spinoff to occur by July 2024 or earlier, subject to the satisfaction of customary conditions.
  • Baxter expects sales growth from continuing operations of 1% to 2% on a reported basis and approximately 1% on a constant currency basis.
  • A webcast of Baxter’s third-quarter 2023 conference call for investors can be accessed live from a link on the company’s website at www.baxter.com beginning at 7:30 a.m. CDT on Nov. 2, 2023.

Siemens Healthineers Selects Baxter Planning To Transform its Service Supply Chain

Retrieved on: 
Wednesday, November 1, 2023
Baxter, Center of excellence, Service, Siemens Healthineers, Automation, Senior, COE, Growth, Partnership, Assumption-based planning, Hospital, Civil Service Supply Association, Spare Parts, Burn, Total cost, Patient, 3D printing, Nursing, Warehouse, Medical imaging

AUSTIN, Texas, Nov. 1, 2023 /PRNewswire/ -- Baxter Planning, the leading provider of Service Parts Management technology, today announced that Siemens Healthineers, a leading medical technology company, has selected Baxter Planning as their long-term Service Supply Chain partner. Siemens Healthineers will be leveraging Baxter Planning's BaxterPredict, an end-to-end predictive platform to support the global Service Supply Chain at Siemens Healthineers Customer Services.

Key Points: 
  • AUSTIN, Texas, Nov. 1, 2023 /PRNewswire/ -- Baxter Planning, the leading provider of Service Parts Management technology, today announced that Siemens Healthineers, a leading medical technology company, has selected Baxter Planning as their long-term Service Supply Chain partner.
  • Siemens Healthineers will be leveraging Baxter Planning's BaxterPredict, an end-to-end predictive platform to support the global Service Supply Chain at Siemens Healthineers Customer Services.
  • After an extensive evaluation, Siemens Healthineers selected Baxter Planning based on their leading Service Parts Planning solution and domain expertise.
  • This new, predictive approach to inventory planning, demand forecasting, product-lifecycle planning, operations-workflow monitoring, reverse logistics, and customer-escalation management unlocks significant new value for Service Supply Chain organizations.